Trupanion, Inc. $TRUP Shares Purchased by Jump Financial LLC

Key Points

• Jump Financial LLC increased its holdings in Trupanion, Inc. by 27.5%, owning 87,673 shares valued at approximately $3.27 million as of the latest quarter.
• Research analysts have a consensus rating of "Moderate Buy" for Trupanion, with price targets ranging from $41 to $67.
• Trupanion reported a quarterly earnings of $0.22 EPS, surpassing analysts' expectations and showing a 12.3% increase in revenue year-over-year.

Jump Financial LLC increased its stake in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 27.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 87,673 shares of the financial services provider's stock after buying an additional 18,919 shares during the period. Jump Financial LLC owned 0.20% of Trupanion worth $3,268,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in TRUP. Balyasny Asset Management L.P. increased its position in Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after purchasing an additional 661,559 shares during the period. Wellington Management Group LLP increased its position in Trupanion by 13.2% during the 1st quarter. Wellington Management Group LLP now owns 2,491,227 shares of the financial services provider's stock valued at $92,848,000 after purchasing an additional 290,788 shares during the period. BNP Paribas Financial Markets increased its position in Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock valued at $16,248,000 after purchasing an additional 212,545 shares during the period. Hosking Partners LLP grew its position in shares of Trupanion by 86.9% in the 1st quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider's stock worth $14,821,000 after buying an additional 184,936 shares during the last quarter. Finally, Freestone Grove Partners LP purchased a new position in shares of Trupanion in the 4th quarter worth approximately $7,776,000.

Trupanion Stock Performance

NASDAQ:TRUP traded up $0.14 during trading hours on Friday, hitting $46.36. 536,451 shares of the company were exchanged, compared to its average volume of 581,874. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of 178.31 and a beta of 1.72. Trupanion, Inc. has a 52-week low of $31.00 and a 52-week high of $57.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69. The company's 50 day moving average price is $50.10 and its 200-day moving average price is $44.03.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.25. The company had revenue of $353.56 million for the quarter, compared to the consensus estimate of $346.73 million. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. Trupanion's revenue was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.14) EPS. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Activity at Trupanion

In other Trupanion news, insider Brenna Mcgibney sold 2,390 shares of Trupanion stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $45.17, for a total transaction of $107,956.30. Following the completion of the sale, the insider directly owned 1,317 shares in the company, valued at approximately $59,488.89. The trade was a 64.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 2,800 shares of Trupanion stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total transaction of $127,568.00. Following the sale, the chief financial officer owned 6,451 shares of the company's stock, valued at approximately $293,907.56. The trade was a 30.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,390 shares of company stock worth $245,238. 5.42% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Stifel Nicolaus lifted their price objective on shares of Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a research report on Friday, August 8th. Cantor Fitzgerald raised shares of Trupanion to a "hold" rating in a research report on Wednesday, August 13th. Finally, Piper Sandler lifted their price objective on shares of Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a research report on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Trupanion has an average rating of "Moderate Buy" and a consensus price target of $54.17.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.